跳至主要内容
临床试验/ISRCTN25669625
ISRCTN25669625已完成不适用

The efficacy of nebulised procaterol versus nebulised salbutamol for the treatment of moderate acute asthma: a randomised, double-blind, parallel group study

Otsuka Indonesia0 个研究点目标入组 140 人开始时间: 2009年8月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with moderate acute asthma according to Global Initiative for Asthma (GINA) 1998 (patients with asthma score 5 to 11; PEFR less than or same 80% predicted)
  • 2. Patients of both genders, aged 15 to 60 years
  • 3. Patients still have the ability to undergo examinations and give written informed consent

排除标准

  • 1. Pregnant and lactating women
  • 2. Smokers
  • 3. Patients with heart disease, hyperthyroidism, diabetes mellitus, chronic obstructive pulmonary disease (COPD) or other chronic diseases
  • 4. Patients with signs of severe infections

研究者

发起方
Otsuka Indonesia

相似试验